ArticleHaematologica2026

Response to Comment on: "Hepatitis B virus reactivation following T-cell engager therapy in multiple myeloma despite negative hepatitis B core antibody serology: implications for screening in patients with hematological malignancies".

Matthew J Rees et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.